Article
Status and future developments for downstream processing of biological products Perspectives from the Recovery XIX yield roundtable discussions
2024-04-13
Abstract excerpt
Governments and biopharmaceutical organizations aggressively leveraged expeditious communication capabilities, decision models and global strategies to make a COVID-19 vaccine happen within a period of 12 months. This was an unusual effort and cannot be transferred to normal times. However, this focus on a single vaccine has also led to other treatments and drug developments being sidelined. Society expects the ph...
Topics
Open a Topic to create a Post that cites this publication.
- Biomedical Ethics and Regulation
- CAR-T cell therapy research
- Monoclonal and Polyclonal Antibodies Research
- Protein purification and stability
- RNA Interference and Gene Delivery
- Viral gastroenteritis research and epidemiology
- Viral Infectious Diseases and Gene Expression in Insects
- Virus-based gene therapy research
Identifiers and source
- Literature Corpus work
- 5767ade2-ce52-5fdd-9234-e9a165367911
- DOI
- 10.22541/au.171302878.84923242/v1